Future Market Insights opines that the catalase market is entering a consolidation-driven restructuring phase, where dsm-firmenich's divestiture of its Animal Nutrition & Health enzyme assets and Novonesis's integration of the former DSM-Firmenich feed enzyme alliance are concentrating catalase production, application knowledge, and distribution capacity among a smaller group of biomanufacturing-scale competitors.